Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dias, C. A. Articles by Teixeira, L. M. Search for Related Content PubMed PubMed Citation Articles by Dias, C. A. Articles by Teixeira, L. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2007, p. 3065-3067, Vol. 45, No. 9
0095-1137/07/$08.00+0     doi:10.1128/JCM.00891-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Diversity of Mutations in the atpC Gene Coding for the c Subunit of F₀F₁ ATPase in Clinical Isolates of Optochin-Resistant Streptococcus pneumoniae from Brazil

Cícero A. Dias,^1,3 Grasiela Agnes,¹ Ana Paula G. Frazzon,¹ Filipe D. Kruger,¹ Pedro A. d'Azevedo,¹ Maria da Glória S. Carvalho,² Richard R. Facklam,² and Lúcia M. Teixeira^3*

Fundação Faculdade Federal de Ciências Médicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil,¹ Centers for Disease Control and Prevention, Atlanta, Georgia 30333,² Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-590, Brazil³

Received 29 April 2007/ Returned for modification 3 June 2007/ Accepted 2 July 2007

Top ABSTRACT TEXT REFERENCES

 
We report the characteristics of four optochin-resistant (Opt^r) Streptococcus pneumoniae isolates from Brazil. All four Opt^r isolates presented mutations in the nucleotide sequence coding for the c subunit of F₀F₁ ATPase. Two isolates showed mutations in codons 23 (leading to the deduced amino acid substitution isoleucine instead of alanine) and 49 (serine instead of alanine, a novel type of mutation detected at this position), respectively. Two additional novel mutations, both located in codon 45, were detected in the other two isolates, corresponding to leucine or valine (instead of phenylalanine). The data indicate that three previously unrecognized alterations were detected in the atpC gene of S. pneumoniae and that Opt resistance among Brazilian pneumococcal isolates is not related to a specific pneumococcal serotype, antimicrobial-resistance profile, or clonal group.

Top ABSTRACT TEXT REFERENCES

 
Streptococcus pneumoniae is one of the most important human pathogens, remaining as a major cause of community-acquired infections, such as pneumonia, bacteremia, meningitis, otitis media, and sinusitis (3). Because of the increasing frequency of antimicrobial resistance, accurate identification and antimicrobial susceptibility testing are essential for correct diagnosis and treatment of patients. Determination of phenotypic characteristics is conventionally used in diagnostic laboratories for the identification of S. pneumoniae, including colony morphology on blood agar plates, optochin (Opt) susceptibility, bile solubility, and reactivity with type-specific antisera for detection of capsular polysaccharide antigen (1, 11). Several commercial systems and rapid kits are also available. More recently, a variety of molecular methods, including a DNA probe directed to a section of rRNA (8), PCR assays for detection of genes encoding diverse virulence factors (4, 12, 14), and DNA-DNA reassociation (1), have been applied to identify pneumococcal isolates. Despite the development of newer methods, most routine laboratories still rely on the results of Opt susceptibility testing as the primary or even the only test for the presumptive identification of pneumococci. Occasionally, however, isolates of S. pneumoniae exhibiting an optochin-resistant (Opt^r) phenotype have been reported (2, 6, 7, 10, 13, 15). The occurrence of such a phenotypic variant is a potential cause of problems in the precise characterization of this agent, leading to misidentification. The Opt^r phenotype is attributed to mutations in the atpC gene that codes for the molecular target of Opt, the transmembrane F₀F₁ ATPase, involved in proton transportation in the respiratory chain (9, 13). Alterations in -helix 1, corresponding to codons 14, 20, and 23 (6, 13), and in -helix 2, corresponding to codons 48, 49, and 50 (7, 13) of the c subunit of the F₀ complex of the molecule, have already been described in clinical isolates of S. pneumoniae. A mutation located in the a subunit of F₀F₁ ATPase was also described (13). To date, reports of the occurrence of Opt^r pneumococci are still sporadic, and only a few isolates with the Opt^r phenotype have had their respective mutations described.

The purpose of this communication is to report the occurrence and characterization of Opt^r S. pneumoniae clinical isolates from Brazil, illustrating the global diversity among isolates from different geographic areas.

Four S. pneumoniae isolates (Sp 910, Sp 913, Sp 917, and Sp 1008) presenting the Opt^r phenotype were investigated. Two of them (Sp 910 and Sp 913) were recovered from lower respiratory tract specimens, one (Sp 917) was isolated from blood, and the other (Sp 1008) was isolated from ocular secretion. These isolates were detected among a collection of about 470 pneumococci obtained in the period 1995 to 1999 during studies of the antimicrobial susceptibility, serotype distribution, and molecular epidemiology of pneumococcal isolates recovered from individuals living in Porto Alegre City, Rio Grande do Sul State, located in the southern region of Brazil. Three of them (Sp 910, Sp 913, and Sp 917) were isolated in 1995, and one (Sp 1008) was isolated in 1996. The isolates were initially subjected to conventional identification tests, including observation of colony characteristics on blood agar plates, cellular characteristics as observed after Gram staining, optochin susceptibility, and bile solubility, according to previously described methods (1, 11). Serotyping was based on capsular swelling (the Quellung reaction) with type-specific pneumococcal antisera (Centers for Disease Control and Prevention, Atlanta, GA), using the Danish system of nomenclature. Susceptibility to antimicrobial agents (ceftriaxone, chloramphenicol, erythromycin, penicillin, tetracycline, and vancomycin) was evaluated by an agar dilution method, based on the Clinical and Laboratory Standards Institute (5) guidelines. The presence of the virulence genes ply (14), psaA (12), and lytA (4) was detected by PCR procedures. A commercial DNA probe (AccuProbe S. pneumoniae culture identification test; Gen-Probe, San Diego, CA) was used, following the manufacturer's instructions. Chromosomal DNA macrorestriction profiles were obtained by treatment with SmaI, followed by pulsed-field gel electrophoresis (PFGE) (11). In order to identify mutations responsible for the Opt^r phenotype, primers 663 (5'-TCGAAAAGTGGATCAACAACTATCC-3') and 1016 (5'-TGGGAAAGAAGAAGTAACAAACTCG-3') were used to amplify a 930-bp fragment coding for the c subunit of the F₀F₁ ATPase gene (9). After purification of the amplicons, sequencing was carried out by the Big Dye Terminator method v3.1 (Perkin-Elmer Applied Biosystems, Foster City, CA), using primer 663 in an automated system (ABI Prism 310 Genetic Analyzer; P-E Applied Biosystems) according to the manufacturer's recommendations. An Opt-susceptible (Opt^s) reference strain (S. pneumoniae R6) was also included in the sequencing experiments for comparative purposes.

No zone of inhibition was observed around optochin disks when the four Opt^r isolates were tested. The observations were consistent when Opt susceptibility tests were incubated under two different conditions, ambient atmosphere and CO₂. Except for resistance to Opt, the four isolates exhibited typical phenotypic and genetic profiles for identification as S. pneumoniae: they all were bile soluble; presented a capsular antigen; possessed the ply, lytA, and psaA genes; and hybridized with the pneumococcal genetic probe. A comparison with the wild-type atpC gene sequence of the Opt^s strain R6, however, revealed that all four isolates with the Opt^r phenotype presented mutations located in the gene coding for the c subunit of F₀F₁ ATPase (Table 1). Isolates Sp 910 and Sp 913 presented changes in codons 23 and 49, respectively. Mutations in these two codons have been previously described, although the nucleotide change observed in isolate Sp 913 was unique, comprising a G-to-T transition at position 145 of the atpC gene sequence obtained in the present study and corresponding to position 357 of the published atpCAB gene cluster sequence (GenBank Z26851). This transition produces an alanine-to-serine amino acid substitution in a region corresponding to transmembrane -helix 1 of the AtpC protein, which differs from two previous reports (7, 13) describing an alanine-to-threonine substitution. Additionally, two novel mutations, both located in codon 45, were observed in two other isolates (Sp 917 and Sp 1008). The nucleotide changes detected corresponded to two different deduced amino acid substitutions: leucine (instead of phenylalanine) in isolate Sp 917 and valine in isolate Sp 1008. The four isolates belonged to different serotypes, as shown in Table 1. Analysis of PFGE profiles indicated that the isolates were not genetically related to each other (data not shown). The isolates were susceptible to most of the antimicrobial agents tested, except for Sp 910, which was resistant to chloramphenicol and sulfamethoxazole-trimethoprim, and Sp 1008, which was resistant to tetracycline.

View this table: [in this window] [in a new window]

TABLE 1. General characteristics and mutations in the atpC gene coding for the c subunit of F0 F1 ATPase in Optr S. pneumoniae isolates

This is the first report of the characterization of Opt^r S. pneumoniae occurring in Brazil. Furthermore, the present communication contains a description of three previously unrecognized alterations occurring in the atpC gene of S. pneumoniae. Such alterations may be considered putative contributors to the Opt^r phenotype, since the results of genetic transformation experiments have demonstrated that point mutations previously detected in the atpC gene were associated with Opt^r in pneumococcal isolates (9, 13). The overall data indicate that the occurrence of Opt resistance among Brazilian pneumococcal isolates is not related to a specific pneumococcal serotype, antimicrobial-resistance profile, or clonal group. Such a finding has also been observed among isolates from the United States (13). When taken in conjunction with the results of other studies, this investigation additionally illustrates the diverse nature of putative molecular mechanisms of Opt resistance in S. pneumoniae and contributes to the global knowledge about the occurrence and diversity of Opt^r pneumococcci.

The prevalence of Opt resistance among S. pneumoniae remains unknown, and it is probably underestimated, as many clinical laboratories still depend on Opt susceptibility testing for screening and identification of this microorganism and therefore may overlook or misidentify S. pneumoniae isolates with the Opt^r phenotype. Clinicians and microbiologists should be aware of the existence of the Opt^r pneumococcal isolates circulating in various areas and consider them a potential cause of life-threatening infections. Since misidentification of Opt^r S. pneumoniae as viridans streptococci may have significant implications for the management of patients, routine use of at least one additional test, such as the bile solubility test, should be adopted to accurately identify S. pneumoniae. As more attention is dedicated to properly detecting and characterizing Opt^r pneumococcal isolates in the clinical setting, more information will became available on the occurrence and diversity of these atypical variants and their roles as agents of infections.

Nucleotide sequence accession numbers. The sequences of the atpC gene reported here have been deposited in the GenBank database under the following accession numbers: EF464066 (isolate Sp 910), EF464067 (isolate Sp 913), EF464068 (isolate Sp 917), and EF464069 (isolate Sp 1008).

 
This study was supported in part by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Ministério da Ciência e Tecnologia (MCT/PRONEX), Brazil.

 
* Corresponding author. Mailing address: Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, CCS, Bloco I, Cidade Universitária, Rio de Janeiro, RJ 21941-590, Brazil. Phone: 55 21 2260 4193. Fax: 55 21 2560 8344. E-mail: lmt2{at}micro.ufrj.br

Published ahead of print on 11 July 2007.

Top ABSTRACT TEXT REFERENCES

 

1
1. Arbique, J. C., C. Poyart, P. Trieu-Cuot, G. Quesne, M. G. S. Carvalho, A. G. Steigerwalt, R. E. Morey, D. Jackson, R. J. Davidson, and R. R. Facklam. 2004. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J. Clin. Microbiol. 42:4686-4696.[Abstract/Free Full Text]
2
2. Borek, A. P., D. C. Dressel, J. Hussong, and L. R. Peterson. 1997. Evolving clinical problems with Streptococcus pneumoniae: increasing resistance to antimicrobial agents, and failure of traditional optochin identification in Chicago, Illinois, between 1993 and 1996. Diagn. Microbiol. Infect. Dis. 29:209-214.[CrossRef][Medline]
3
3. Centers for Disease Control and Prevention. 1997. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 46:1-24.[Medline]
4
4. Cherian, T., M. K. Latitha, A. Manoharan, K. Thomas, H. R. Yolken, and M. C. Steinhoff. 1998. PCR-enzyme immunoassay for detection of Streptococcus pneumoniae DNA in cerebrospinal fluid samples from patients with culture-negative meningitis. J. Clin. Microbiol. 36:3605-3608.[Abstract/Free Full Text]
5
5. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. M110-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
6
6. Cogné, N., J. P. Claverys, F. Denis, and C. Martin. 2000. A novel mutation in the -helix 1 of the C subunit of the F₁/F₀ ATPase responsible for optochin resistance of a Streptococcus pneumoniae clinical isolate. Diagn. Microbiol. Infect. Dis. 38:119-121.[CrossRef][Medline]
7
7. de la Campa, A. G., E. Garcia, A. Fenoll, and R. Muñoz. 1997. Molecular bases of three characteristic phenotypes of pneumococcus: optochin-sensitivity, coumarin-sensitivity, and quinolone-resistance. Microb. Drug Resist. 3:177-193.[Medline]
8
8. Denis, G. A., and R. Carey. 1992. Identification of Streptococcus pneumoniae with a DNA probe. J. Clin. Microbiol. 30:2725-2727.[Abstract/Free Full Text]
9
9. Fenoll, A., R. Muñoz, E. Garcia, and A. G. de la Campa. 1994. Molecular basis of the optochin-sensitive phenotype of pneumococcus: characterization of the genes encoding the F₀ complex of the Streptococcus pneumoniae and Streptococcus oralis H⁺-ATPases. Mol. Microbiol. 12:587-598.[Medline]
10
10. Kontiainem, S., and A. Sinoven. 1987. Optochin resistance in Streptococcus pneumoniae strains isolated from blood and middle ear fluid. Eur. J. Clin. Microbiol. 6:422-424.[CrossRef][Medline]
11
11. Mendonca-Souza, C. R. V., M. G. S. Carvalho, R. R. Barros, C. A. G. Dias, J. L. M. Sampaio, A. C. D. Castro, R. R. Facklam, and L. M. Teixeira. 2004. Occurrence and characteristics of erythromycin-resistant Streptococcus pneumoniae strains isolated in three major Brazilian states. Microb. Drug Resist. 10:313-320.[CrossRef][Medline]
12
12. Morrison, K. E., D. Lake, J. Crook, G. M. Carlone, E. Ades, R. Facklam, and J. S. Sampson. 2000. Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J. Clin. Microbiol. 38:434-437.[Abstract/Free Full Text]
13
13. Pikis, A., J. M. Campos, W. J. Rodriguez, and L. M. Keith. 2001. Optochin resistance in Streptococcus pneumoniae: mechanisms, significance, and clinical implications. J. Infect. Dis. 184:582-590.[CrossRef][Medline]
14
14. Rudolph, K. M., A. J. Parkinson, C. M. Black, and L. W. Mayer. 1993. Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia. J. Clin. Microbiol. 31:2661-2666.[Abstract/Free Full Text]
15
15. Verhelst, R., T. Kaijalainen, T. de Baere, G. Verschragen, G. Clayers, L. van Simaey, C. de Ganck, and M. Vaneechoutte. 2003. Comparison of five genotypic techniques for identification of optochin-resistant pneumococcus-like isolates. J. Clin. Microbiol. 41:3521-3525.[Abstract/Free Full Text]

---

Journal of Clinical Microbiology, September 2007, p. 3065-3067, Vol. 45, No. 9
0095-1137/07/$08.00+0     doi:10.1128/JCM.00891-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Cortes, P. R., Orio, A. G. A., Regueira, M., Pinas, G. E., Echenique, J. (2008). Characterization of In Vitro-Generated and Clinical Optochin-Resistant Strains of Streptococcus pneumoniae Isolated from Argentina. J. Clin. Microbiol. 46: 1930-1934 [Abstract] [Full Text]  
• Nunes, S., Sa-Leao, R., de Lencastre, H. (2008). Optochin Resistance among Streptococcus pneumoniae Strains Colonizing Healthy Children in Portugal. J. Clin. Microbiol. 46: 321-324 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dias, C. A. Articles by Teixeira, L. M. Search for Related Content PubMed PubMed Citation Articles by Dias, C. A. Articles by Teixeira, L. M.